Aspira Women's Health Inc. engages in developing and commercializing diagnostic tests for gynecologic disease in the United States.The company provides OVA1, OVERA, and OVAInherit tests to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of Gynecologic cancer.
